Compare PEB & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PEB | SSII |
|---|---|---|
| Founded | 2009 | N/A |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2009 | N/A |
| Metric | PEB | SSII |
|---|---|---|
| Price | $11.26 | $5.49 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $12.28 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 80.7K |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | ★ 0.35% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,464,126,000.00 | $36,066,457.00 |
| Revenue This Year | $2.32 | N/A |
| Revenue Next Year | $2.42 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.99 | ★ 158.36 |
| 52 Week Low | $7.42 | $3.02 |
| 52 Week High | $14.85 | $22.42 |
| Indicator | PEB | SSII |
|---|---|---|
| Relative Strength Index (RSI) | 56.64 | 32.40 |
| Support Level | $10.67 | $5.82 |
| Resistance Level | $11.71 | $6.30 |
| Average True Range (ATR) | 0.34 | 0.48 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 61.24 | 7.48 |
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.